104 related articles for article (PubMed ID: 1244078)
1. The excretion of 3-hydroxyanthranilic acid in patients with bladder and kidney carcinoma.
Teulings FA; Mulder-Kooy GE; Peters HA; Fokkens W; Van Der Werf-Messing B
Acta Vitaminol Enzymol; 1975; 29(1-6):108-12. PubMed ID: 1244078
[TBL] [Abstract][Full Text] [Related]
2. [3-hydroxyanthranilic acid content in the urine of bladder cancer patients].
Korosteleva TA; Kliucharev BV; Benteleva TA
Vopr Onkol; 1979; 25(6):36-9. PubMed ID: 462869
[TBL] [Abstract][Full Text] [Related]
3. A new aspect of the urinary excretion of tryptophan metabolites in patients with cancer of the bladder.
Teulings FA; Peters HA; Hop WC; Fokkens W; Haije WG; Portengen H; van der Werf-Messing B
Int J Cancer; 1978 Feb; 21(2):140-6. PubMed ID: 627424
[No Abstract] [Full Text] [Related]
4. [Proceedings: Tryptophan metabolism, bladder carcinoma and smoking habits].
Schievelbein H; Kuntze I
Z Klin Chem Klin Biochem; 1972 Apr; 10(4):179. PubMed ID: 4282664
[No Abstract] [Full Text] [Related]
5. [Proceedings: Endogenous carcinogens. Experimental induction of malignant tumors and leukemias by the tryptophan metabolites 3-hydroxyanthranilic acid and 3-hydroxykynurenine].
Ehrhart H
Z Klin Chem Klin Biochem; 1972 Apr; 10(4):178-9. PubMed ID: 4681017
[No Abstract] [Full Text] [Related]
6. Urinary tryptophan metabolites and cancer of the bladder in humans.
Friedlander E; Morrison AS
J Natl Cancer Inst; 1981 Aug; 67(2):347-51. PubMed ID: 6943373
[TBL] [Abstract][Full Text] [Related]
7. Effect of smoking on excretion of tryptophan metabolite in urine-3-hydroxy anthranilic acid.
Sulochana G; Arunagiri R
Indian J Exp Biol; 1978 Apr; 16(4):507-8. PubMed ID: 680862
[No Abstract] [Full Text] [Related]
8. Alterations of the tryptophan--nicotinic acid metabolism in vitiligo.
De Antoni A; Cardin Dè Stefani EL; Costa C; Vanzan S; Allegri G
Acta Vitaminol Enzymol; 1982; 4(3):237-43. PubMed ID: 7148608
[TBL] [Abstract][Full Text] [Related]
9. Studies in the etiology and prevention of bladder carcinoma.
Schlegel JU; Pipkin GE; Nishimura R; Duke GA
Trans Am Assoc Genitourin Surg; 1968; 60():14-21. PubMed ID: 5746137
[No Abstract] [Full Text] [Related]
10. Kinetics of urinary excretion of 3-hydroxykynurenine and 3-hydroxyanthranilic acid after tryptophan loading in man.
Hansson O
Acta Soc Med Ups; 1968; 73(1):11-8. PubMed ID: 5677553
[No Abstract] [Full Text] [Related]
11. A new method for determination of urinary tryptophan metabolites in bladder carcinoma.
Romas NA; Ionascu L; Sholem S; Ionescu G; Veenema RJ
J Urol; 1975 Aug; 114(2):223-5. PubMed ID: 1159913
[TBL] [Abstract][Full Text] [Related]
12. Effect of 4-desoxypyridoxine on the initial excretion rates of 3-hydroxykynurenine and 3-hydroxyanthranilic acid after tryptophan loading.
Hansson O
Acta Soc Med Ups; 1968; 73(1):19-34. PubMed ID: 5677554
[No Abstract] [Full Text] [Related]
13. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
[TBL] [Abstract][Full Text] [Related]
14. [Urinary excretion of metabolites of the tryptophan-kynurenine pathway in healthy infants after an oral loading dose of L-tryptophan (author's transl)].
Cruz M; Rodríguez-Hierro F; Torralba A
Rev Esp Fisiol; 1972 Dec; 28(4):283-6. PubMed ID: 4680088
[No Abstract] [Full Text] [Related]
15. Studies on the role of tryptophan metabolites in the genesis of bladder cancer.
Wolf H
Acta Chir Scand Suppl; 1973; 433():154-68. PubMed ID: 4513505
[No Abstract] [Full Text] [Related]
16. [Endogenous risk factors for bladder neoplasms in women].
Prianichnikova MB
Vopr Onkol; 1991; 37(9-10):925-9. PubMed ID: 1842651
[TBL] [Abstract][Full Text] [Related]
17. Absorption of 14 C-labeled 3-hydroxy-L-kynurenine and 3-hydroxyanthranilic acid from the mouse urinary bladder under carcinogenic conditions.
Bryan GT; Morris CR; Brown RR
Cancer Res; 1965 Oct; 25(9):1432-7. PubMed ID: 5861071
[No Abstract] [Full Text] [Related]
18. [Diagnostic significance of determining 3-hydroxyanthranilic acid in patients with precancerous diseases and cancer of the bladder].
Klimenko IA; Romanenko AM; Korosteleva TA; Belokhvostova AT
Urol Nefrol (Mosk); 1986; (6):30-4. PubMed ID: 3811070
[No Abstract] [Full Text] [Related]
19. Urinary tryptophan metabolites: assay of free and acid hydrolyzable conjugates of 3-hydroxykynurenine and 3-hydroxyanthranilic acid.
Yeh JK; Brown RR
Biochem Med; 1975 Sep; 14(1):12-23. PubMed ID: 1212237
[No Abstract] [Full Text] [Related]
20. [Tryptophan metabolic disorder--1 of the criteria for forming groups at high risk for spontaneous bladder cancer].
Prianichnikova MB
Urol Nefrol (Mosk); 1984; (4):61-5. PubMed ID: 6236595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
